(Q78067139)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428146%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

Comparison of finasteride and flutamide in the treatment of idiopathic hirsutism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428146%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

L Falsetti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428146%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

A Gambera

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428146%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

English

0 references

publication date

1 July 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428146%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428146%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428146%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428146%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

41-46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428146%20AND%20SRC:MED&resulttype=core&format=json

Increased 5 alpha-reductase activity in idiopathic hirsutism

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

5 alpha-Reductase activity in the genital skin of hirsute women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

Androstanediol glucuronide plasma clearance and production rates in normal and hirsute women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

Identification and selective inhibition of an isozyme of steroid 5 alpha-reductase in human scalp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

Flutamide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in advanced prostatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

Flutamide-induced liver toxicity including fatal hepatic necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

Clinical assessment of body hair growth in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

Finasteride in the treatment of hirsutism: new therapeutic perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

Outcome of long-term treatment with the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

Comparison of the efficacy of spironolactone**Spironolactone (Aldactone; Searle, Chicago, IL). versus flutamide††Flutamide (Eulexin; Schering Plough Laboratories, Heist, Belgium). in the treatment of hirsutism‡‡Presented in part at the 3rd Wo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

Comparison of flutamide and cyproterone acetate in the treatment of hirsutism: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

Hyperandrogenic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Hirsutism in polycystic ovary syndrome: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900183-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0015-0282(99)00183-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10428146%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference